Author:
Schwabe Ulrich,Ziegler Reinhard
Publisher
Springer Berlin Heidelberg
Reference19 articles.
1. American Medical Association (1986): Agents affecting calcium metabolism. In: Drug Evaluations, 6th ed, Saunders Company, Philadelphia, pp. 827–839, 885–902.
2. Arzneimittelkommission der Deutschen Ärzteschaft (2003): Empfehlungen zur Therapie und Prophylaxe der Osteoporose. Arzneiverordnung in der Praxis (Sonderheft 34S).
3. Bone HG, Greenspan SL, McKeever C et al (2000): Alendronate and estrogen effects in postmenopausal women with low bone mineral density. J Clin Endocrinol Metab 85: 720–726.
4. Crowther CA, Hiller JE, Doyle LW, Haslam RR (2003): Effect of magnesium sulfate given for neuroprotection before preterm birth. JAMA 290:2669–2676.
5. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997): Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670–676.